Parental acceptance of human papilloma virus vaccine for their pre-pubertal and teenage daughters

East African Medical Journal

Volumn 88, Issue 5, 2011, Pages 163-170

  Omondi Ogutu, ^a   M'Imunya J M ^a  

^a UNIVERSITY OF NAIROBI   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84909962479     PISSN: 0012835X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. World Health Organization (WHO). The World Health Report 2004 – changing. The history, Annex Table 2: Deaths by cause, sex and mortality stratum. In WHO regions, estimates for 2002, Geneva: WHO, 2004. Available at: Http://www.who.int/whr/2004/en/.
2. Farley, J., Bray, F., Pisani, P., et al. Globocan 2002: Cancer incidence and Mortality worldwide. IARC CancerBase No. 5, version 2.0. Lyon: IARC Press, 2004.
3. Dempsey, A. F., Koutsky, L. A. and Golden, M.Potential impact of human Papillomavirus vaccines on public STD clinic workloads and on Opportunities to diagnose and treat other sexually transmitted diseases. Sex Transm. Dis. 2007; 34:1–5.
4. Harper, D. M., Franco, E. L., Wheeler, C. M., et al: Sustained efficacy up to 4.5 years of a bivalent L1 virus like particle vaccine against human papillomavirus types 16 and 18:follow-up from randomised control trial. Lancet 2006; 367:1247–1255.
5. Villa, L. L., Costa, R. L. R., Petta, C. A., et al. High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up. Br. J. Cancer. 2006; 95:1459–1466.
6. FUTURE II Study Group. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. New Engl. J. Med. 2007; 356: 1915–1927.
7. Garland, S. M., Hernandez-Avila, M., Wheeler, C. M., et al. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. New Engl. J. Med. 2007; 356: 1928–1943.
8. Parkin, D. M. and Bray, F. Chapter 2: The burden of HPV- related cancers. Vaccine 2006; 24(Suppl 3):S11–25.
9. World Health Organization (WHO). Health Statistics and Health Information Systems - Years of Life Lost by age, sex and cause for the year 2002. Revised Global Burden of Disease 2002 estimates. Geneva: WHO, 2002. Available at: Http://www.who.int/healthinfo/bodgbd2002revised/en/index.html.(last accessed: April 2008).
10. World Health Organization (WHO). Health Statistics and Health Information Systems - Disability Adjusted Life Years by age sex and cause for the year 2002. Revised Global Burden of Disease 2002 estimates. Geneva: WHO 2002. Available at: Http://www.who.int/healthinfo/bodgbd2002revised/en/index.html.
11. Goldie, S. J., Kholi, M., Grima, D., et al. Projected clinical benefits and cost effectiveness of a human papilloma virus 16/18 vaccine. J. Natl. cancer institute 2004; 96: 60-115.
12. Bosch, F. X. and Munoz, N. Viral Aetiology of cervical cancer Virus Res. 2002; 183-190.
13. Olyse, O., Woods, R. E. and Austin, B. S. Parental acceptance of HPV vaccine journal of adolescent health 37: 248-251.
14. Lenselink, C. H., Gerrits, M. M., Melchers, W. J., et al. Parental acceptance of Human Papillomavirus vaccines. Eur. J. Obstet. Gynecol. Reprod. Biol. 2008; 137: 103-107.
15. Brabin, L., Roberts, S. A., Farzaneh, F. and Kitchener, H. C. Future acceptance of adolescent human papillomavirus vaccination: A survey of parental attitudes. Vaccine 2006; 24: 3087–3094.
16. Waller, J., Marlow, L. A. and Wardle, J. Mothers’ attitudes towards preventing cervical cancer through human papillomavirus vaccination: A qualitative study. Cancer Epidemiol Biomarkers Prev. 2006; 15: 1257–1261.
17. Zur Hausen, 1977; IARC_Monographs, 1995.
18. Mun˜oz, N. and Bosch, F. X. The causal link between HPV and cervical cancer and its implications for prevention of cervical cancer. Bull Pan. Am. Health Organ. 30: 362–377.
19. MOH National guidelines for prevention and management of cervical, breast and prostate cancers 2009.
20. Oteng, B., Marra, F., Lynd, L. D., et al. Evaluating societal preferences for human papillomavirus vaccine and cervical smear test screening programme.
21. Stretch, 21. R., Roberts, S. A., McCann, R., et al. Br. J. Cancer. 2008; 99: 1908-1911.
22. Allen, J. D., Othus, M. K., Shelton, R. C., et al: Parental decision making about the HPV vaccine. Cancer Epidemiology Biomakers Prev. 2010 Sep; 19: 2187-2198.
23. HPV vaccine acceptability among Kenyan women; Becker-Drep S, Otieno., W. A. Brewer N. T., Agot, K. Smith, J. S.: Vaccine. 2010; 28: 4864-4867.